| Attribute |
Value |
| 52 Week Change |
0.80989325 |
| Address1 |
Robert J. Coury Global Center |
| Address2 |
1,000 Mylan Boulevard |
| All Time High |
76.69 |
| All Time Low |
1.0 |
| Ask |
19.75 |
| Ask Size |
2 |
| Audit Risk |
5 |
| Average Analyst Rating |
2.0 - Buy |
| Average Daily Volume10 Day |
8,510,290 |
| Average Daily Volume3 Month |
9,259,762 |
| Average Volume |
9,259,762 |
| Average Volume10Days |
8,510,290 |
| Beta |
0.858 |
| Bid |
18.54 |
| Bid Size |
1 |
| Board Risk |
1 |
| Book Value |
12.344 |
| City |
Canonsburg |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
5 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
18.655 |
| Current Ratio |
1.585 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
18.665 |
| Day Low |
18.17 |
| Debt To Equity |
95.535 |
| Display Name |
Viatris |
| Dividend Date |
1,789,516,800 |
| Dividend Rate |
0.48 |
| Dividend Yield |
2.57 |
| Earnings Call Timestamp End |
1,793,908,800 |
| Earnings Call Timestamp Start |
1,793,908,800 |
| Earnings Timestamp |
1,793,881,800 |
| Earnings Timestamp End |
1,793,881,800 |
| Earnings Timestamp Start |
1,793,881,800 |
| Ebitda |
4,292,499,968 |
| Ebitda Margins |
0.29127002 |
| Enterprise To Ebitda |
7.814 |
| Enterprise To Revenue |
2.276 |
| Enterprise Value |
33,540,163,584 |
| Eps Current Year |
2.51879 |
| Eps Forward |
2.68227 |
| Eps Trailing Twelve Months |
-0.36 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,787,270,400 |
| Exchange |
NMS |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
16.9782 |
| Fifty Day Average Change |
1.6767998 |
| Fifty Day Average Change Percent |
0.09876192 |
| Fifty Two Week Change Percent |
80.98933 |
| Fifty Two Week High |
18.67 |
| Fifty Two Week High Change |
-0.01499939 |
| Fifty Two Week High Change Percent |
-0.0008033953 |
| Fifty Two Week Low |
9.92 |
| Fifty Two Week Low Change |
8.735001 |
| Fifty Two Week Low Change Percent |
0.8805444 |
| Fifty Two Week Range |
9.92 - 18.67 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
322,151,400,000 |
| Five Year Avg Dividend Yield |
3.9 |
| Float Shares |
1,141,791,206 |
| Forward Eps |
2.68227 |
| Forward P E |
6.9549303 |
| Free Cashflow |
2,677,337,600 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
30,000 |
| Fullday Change |
0.38440132 |
| Fullday Change Percent |
2.1097767 |
| Fullday Price |
18.655 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.40307 |
| Gross Profits |
5,940,199,936 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00318 |
| Held Percent Institutions |
0.94134 |
| Implied Shares Outstanding |
1,148,590,864 |
| Industry |
Drug Manufacturers - Specialty & Generic |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
| Industry Key |
drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,787,270,400 |
| Last Dividend Value |
0.12 |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,065,657,600 |
| Last Split Factor |
3:2 |
| Long Business Summary |
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania. |
| Long Name |
Viatris Inc. |
| Market |
us_market |
| Market Cap |
21,426,962,432 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_290203 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-17 |
| Net Income To Common |
-410,700,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
19,686,847,408 |
| Number Of Analyst Opinions |
10 |
| Open |
18.32 |
| Operating Cashflow |
2,330,800,128 |
| Operating Margins |
0.12550999 |
| Overall Risk |
3 |
| Payout Ratio |
9.6 |
| Peg Ratio |
3.39 |
| Phone |
724 514 1800 |
| Post Market Change |
-0.050600052 |
| Post Market Change Percent |
-0.27124122 |
| Post Market Price |
18.6044 |
| Post Market Time |
1,792,194,306 |
| Prev Name |
Mylan, Inc. |
| Previous Close |
18.22 |
| Price Eps Current Year |
7.4063344 |
| Price Hint |
2 |
| Price To Book |
1.5112606 |
| Price To Sales Trailing12 Months |
1.4539273 |
| Profit Margins |
-0.02787 |
| Quick Ratio |
0.816 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.0 |
| Region |
US |
| Regular Market Change |
0.435001 |
| Regular Market Change Percent |
2.38749 |
| Regular Market Day High |
18.665 |
| Regular Market Day Low |
18.17 |
| Regular Market Day Range |
18.17 - 18.665 |
| Regular Market Open |
18.32 |
| Regular Market Previous Close |
18.22 |
| Regular Market Price |
18.655 |
| Regular Market Time |
1,792,180,800 |
| Regular Market Volume |
9,415,660 |
| Return On Assets |
0.02668 |
| Return On Equity |
-0.02754 |
| Revenue Growth |
0.049 |
| Revenue Per Share |
12.715 |
| Sand P52 Week Change |
0.13723719 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
7 |
| Shares Outstanding |
1,148,590,864 |
| Shares Percent Shares Out |
0.0366 |
| Shares Short |
42,038,581 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
38,610,690 |
| Short Name |
Viatris Inc. |
| Short Percent Of Float |
0.0367 |
| Short Ratio |
4.65 |
| Source Interval |
15 |
| State |
PA |
| Symbol |
VTRS |
| Target High Price |
26.0 |
| Target Low Price |
13.0 |
| Target Mean Price |
19.7 |
| Target Median Price |
20.0 |
| Total Cash |
1,510,499,968 |
| Total Cash Per Share |
1.315 |
| Total Debt |
13,623,700,480 |
| Total Revenue |
14,737,300,480 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.48 |
| Trailing Annual Dividend Yield |
0.026344677 |
| Trailing Eps |
-0.36 |
| Trailing Peg Ratio |
1.0487 |
| Triggerable |
1 |
| Two Hundred Day Average |
15.59945 |
| Two Hundred Day Average Change |
3.0555506 |
| Two Hundred Day Average Change Percent |
0.19587553 |
| Type Disp |
Equity |
| Volume |
9,415,660 |
| Website |
https://www.viatris.com |
| Zip |
15,317 |